Hexagon Nutrition will host its maiden earnings conference call on July 17, 2026, to discuss the operational and financial performance for the financial year ended March 31, 2026. The meeting is scheduled for 4:00 PM IST and will address analysts and institutional investors regarding the audited financial results for both standalone and consolidated segments. This session marks the company's first such interaction since listing, providing stakeholders with insights into its full-year performance.

The conference call will feature key management personnel, including Managing Director Mr. Vikram Kelkar, Joint Managing Director Dr. Nikhil Kelkar, and Chief Financial Officer Mr. Soman Jana. The discussion will focus on the financial outcomes for FY26, offering a detailed review of the company's operational metrics and strategic progress during the period.

Participants can join the call via specific access numbers provided for different regions. Domestic participants can dial +91 22 6280 1102 or +91 22 7115 8003. International toll-free access is available for the USA, UK, Singapore, and Hong Kong. Additionally, a Diamond Pass link has been issued for streamlined registration and access to the event.

Hexagon Nutrition clarified that no unpublished price sensitive information (UPSI) will be disclosed during this investor meeting. The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also made the relevant details available on its official website.

The following table outlines the contact details for the earnings call:

Hexagon Nutrition Ltd accepted the resignations of Executive Director Subhash Purushottam Kelkar and Non-Executive Director Aditya Kelkar from its board effective July 6, 2026. The directors stepped down following the complete divestment of their shareholding in the company. Both individuals were selling shareholders in the recently concluded initial public offering (IPO) and have fully exited the company.

The company disclosed the changes in a regulatory filing submitted to BSE Limited and National Stock Exchange of India Limited. The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignations were recorded by Company Secretary and Compliance Officer Vedanti Swapnil Vartak.

In their resignation letters, both directors confirmed they no longer hold any shares in the company as of the resignation date. They stated their departure was appropriate given the agreed terms and applicable requirements following the IPO. The directors affirmed there were no other material reasons for their resignations beyond the share divestment.

Subhash Purushottam Kelkar and Aditya Kelkar confirmed they will remain bound by the terms of a Non-Compete Agreement dated April 20, 2026. This agreement includes provisions related to confidentiality, non-compete, and non-solicitation obligations for the duration agreed upon by the parties. The company acknowledged the contributions made by both directors during their respective tenures.

The details of the director changes were provided in Annexure A to the regulatory filing. The company requested the exchanges to take the information on record and file the necessary intimations with the Registrar of Companies and other regulatory authorities.

Director Resignation Details